FMP
Puma Biotechnology, Inc.
PBYI
NASDAQ
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
5.13 USD
-0.04 (-0.78%)
About
ceo
Mr. Alan H. Auerbach
sector
Healthcare
industry
Biotechnology
website
https://www.pumabiotechnology.com
exchange
NASDAQ
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limite...
CIK
0001401667
ISIN
US74587V1070
CUSIP
74587V107
Address
10880 Wilshire Boulevard
Phone
424 248 6500
Country
US
Employee
185
IPO Date
Apr 24, 2012
Summary
CIK
0001401667
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
74587V107
ISIN
US74587V1070
Country
US
Price
5.13
Beta
1.31
Volume Avg.
581.65k
Market Cap
247.3M
Shares
-
52-Week
2.13-7.73
DCF
-0.19
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
11.4
P/B
-
Website
https://www.pumabiotechnology.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PBYI News
It looks like there's no news available.
